BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 17, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 21, 2012
View Archived Issues
Afatinib demonstrates significant improvements in PFS in the LUX-lung 3 phase III trial
Read More
Korean researchers patent novel antiviral compositions
Read More
Janssen Pharmaceutica presents new BACE1 inhibitors
Read More
Treventis prepares new anti-amyloid compounds
Read More
Novel cannabinoid CB1 receptor allosteric modulators discovered at University of Aberdeen
Read More
New efflux pump inhibitors for bacterial infections disclosed
Read More
Theravance presents new dual MABA bronchodilators for COPD
Read More
Ten major pharma companies form nonprofit organization
Read More
Almirall launches aclidinium in Europe
Read More
Cancer Therapeutics CRC synthesizes novel FADK inhibitors
Read More
Bayer submits European MAA for contraceptive patch
Read More
Identification of a new series of potent and selective NS5B inhibitors
Read More
Patrys cleared to commence phase I/IIa PAT-SM6 study
Read More
Murdoch Children's Research Institute receives grant to fight rotavirus
Read More
Intercell reports outcome of vaccine enhancement patch study in influenza
Read More
Plasma serotonin as indicator of stable heart disease outcomes
Read More
Scripps Research Institute receives grant for HIV research
Read More
The Leukemia & Lymphoma Society to support BET inhibitor program
Read More
Bayer College of Medicine presents novel Ndufs4-mutant mouse model
Read More
Sanofi and the TB Alliance to accelerate tuberculosis drug discovery
Read More
Cytochroma begins first of two identical phase III studies of CTAP-101
Read More
FDA approves sNDA for Aerospan inhalation aerosol
Read More
Dyax grants Kadmon exclusive license for anticancer candidate
Read More
Second phase I study confirms GAL-021's effects on respiration
Read More
Biovest provides update on planned MAA for NHL vaccine candidate
Read More